Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

In Brief: Genzyme Transgenics

This article was originally published in The Tan Sheet

Executive Summary

Genzyme Transgenics: Plans to develop a nutritional supplement or "nutraceutical" containing prolactin, "a protein normally produced by the body" with a "broad effect on the immune system," according to SBC Warburg Dillon Read analysts Mary Ann Gray, PhD, and Susan Burnett. Genzyme has produced the protein in the milk of transgenic animals. "Prolactin is also present in human milk and is thought to aid in the maturation of the immune systems in nursing infants," the analysts add. Nutritional supplements "face fewer hurdles and a shorter development timeline than traditional pharmaceuticals," they note...
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS087829

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel